Thomas G. Paese, Esp., Chairman.

• Chair, State Government Relations Section, Buchanan Ingersoll & Rooney.
• Advisor, Institute for Human Virology Board of Advisors
• Former Pennsylvania Secretary of Administration under Governor Tom Ridge
• Former Manager, Government Affairs Group, Klett Rooney Lieber & Schorling
• Former Member, Board of Directors, Public School Employees Retirement System, and the State Employees Retirement System
• Former Co-Chair, Pennsylvania Governor Ed Rendell’s transition team for the Pennsylvania Department of Public Welfare
• Former Chairman, Pennsylvania employees Benefit Trust Fund
• Former General Counsel and Vice President, NovaCare (NYSE: NOV)
• Founder, VP, and General Counsel, Rehab Systems Company (acquired by NovaCare)
• J.D., Dickerson School of Law, Pennsylvania State University
• B.A., Government and International Relations, University of Notre Dame

Joseph Berardino, Director. 

• Managing Director, Alvarez & Marsal, a global professional services firm specializing in performance improvement, turnaround management and business advisory services
• Director, ShopNBC
• Nonexecutive Chairman, Tao Group Limited, UK
• Board of Trustees Member, Fairfield University
• Former Chairman and CEO, Profectus BioSciences
• Former CEO, Andersen Worldwide
• Former Director, Foreign Policy Association
• CPA
• BS, Accounting, Fairfield University

Stewart Greenebaum, Director. 

• President, Greenebaum and Rose Associates, a privately-held, full-service, real estate development and management company
• Director, Hadassah Hospital, Jerusalem, Israel
• Founder and Chairman of the Board, The Children’s House at John’s Hopkins
• Former Chairman, Board of the University of Maryland Medical System (UMMS)
• Former Chairman, Board of Advisors for the Institute for Human Virology.

William A. Haseltine, Ph.D., Director. 

• Chairman, Haseltine Global Health, LLC, a virtual pharmaceutical company dedicated to developing new and more efficient means to develop new life-saving drugs and medical devices
• President, Haseltine Foundation for Medical Sciences and the Arts
• Founder and former Chairman and CEO, Human Genome Sciences, Inc
• Founder, Eight other successful biotechnology companies
• Advisor, CMEA (a venture capital company), the Reliance Innovation Council, India and to several biotechnology and pharmaceutical companies.
• Former Professor, Harvard Medical School from 1976-1993
• Adjunct Professor, Scripps Institute for Medical Research and the Institute of Chemical Engineering the University of Mumbai, India
• Chairman of the Board, Berkeley Center for Synthetic Biology
• Co-Chair, President’s Council of the Cold Spring Harbor Laboratory
• Governor, New York Academy of Science
• Member, Advisory Board of the Global Coalition on HIV/AIDS, Executive Committee of the Brookings Institution, Council on Foreign Relations, Trilateral Commission, Chairman’s Circle of the Asia Society
• Founder, American Freedom Campaign.
• Ph.D., Harvard University

Thomas Lynch, Director . 

• Chairman, Chief Executive Officer Amarin Corporation PLC, (biotech specialty pharmaceutical company, specializing in neurological diseases)
• Non-executive director of ICON PLC, a clinical research company; IDA Ireland (an agency of the Irish government responsible for inward investment); Neuronyx Inc., (a company specialising in stem cell research); and Tripep AB (a Swedish company conducting research in AIDS/HIV and Hepatitis.)
• Board Member, IDA Ireland
• Former Chief Financial Officer and Executive Vice-President, Elan Corporation, PLC.
• Founder and Former Board Member, a company which became Warner Chilcott, PLC
• Former Director, Board of Directors, Galen PLC, Nanogen Inc,
• Advisory Board Member, numerous healthcare investment funds
• Graduate, Queens University Belfast
• Ireland Fellow, Institute of Chartered Accountants

Alexander Rich, M.D., Director. 

• William Thompson Sedgwick Professor of Biophysics and Biochemistry, Massachusetts Institute of Technology
• Founder and Director, Board of Directors, Alkermes, Inc. (NASDAQ “ALKS”)
• Co-Chairman, Board of Directors, Repligen Corporation
• Member, Scientific Advisory Board, Rosetta Genomics, Inc, National Academy of Sciences, Institute of Medicine, USA.
• A.B. and an M.D., Harvard University.

M.G. Sarngadharan, Ph.D., Director. 

• Former Vice President and Scientific Director, Advanced BioScience Laboratories, Inc., Kensington, MD
• Fellow, American Academy of Microbiology
• PhD., Chemistry, Delhi University

Frederick C. Tecce, Esq., Director. 

• Managing Director, Cross Atlantic Capital Partners
• Of counsel to Cross Atlantic Capital Partners, and Buchanan, Ingersoll & Rooney PC.
• Director, Board of Directors and Chairman, Investment Committee, Pennsylvania Public School Employees Retirement System
• Co-founder, Lex Tex Ltd., Militran Inc., and numerous other seed stage and emerging growth companies
• Member, Board of Visitors, Institute for Human Virology
• Director, Board of Directors of Mikros Systems Corp. (OTC “MKRS.OB”) and NutriSystem Inc. (Nasdaq “NTRI”)
• Chairman, Executive Committee of the Eastern Technology Council
• B.A., University of Pennsylvania
• J.D., Dickinson School of Law of Pennsylvania State University.

Brian K. Adamsky, Director. 

• CAO and Managing Director for XACP.
• Former CFO for Megasystems, Inc.
• Former General Manager of Maritank, Inc.
• B.S. Accounting - LaSalle University
• CPA, Commonwealth of Pennsylvania